Stanley V. D’Andrea
Bristol-Myers Squibb (United States)(US)
Publications by Year
Research Areas
Hepatitis C virus research, HIV/AIDS drug development and treatment, Asymmetric Synthesis and Catalysis, Monoclonal and Polyclonal Antibodies Research, Crystallization and Solubility Studies
Most-Cited Works
- → 4-Thiazolidinones: novel inhibitors of the bacterial enzyme murB(2000)218 cited
- → The Discovery of Asunaprevir (BMS-650032), An Orally Efficacious NS3 Protease Inhibitor for the Treatment of Hepatitis C Virus Infection(2014)110 cited
- → Discovery and Early Clinical Evaluation of BMS-605339, a Potent and Orally Efficacious Tripeptidic Acylsulfonamide NS3 Protease Inhibitor for the Treatment of Hepatitis C Virus Infection(2014)66 cited
- → Discovery of isoxazolinone antibacterial agents. Nitrogen as a replacement for the stereogenic center found in oxazolidinone antibacterials(2004)42 cited
- → Potent Inhibitors of Hepatitis C Virus NS3 Protease: Employment of a Difluoromethyl Group as a Hydrogen-Bond Donor(2018)40 cited
- → Discovery of a Potent Acyclic, Tripeptidic, Acyl Sulfonamide Inhibitor of Hepatitis C Virus NS3 Protease as a Back-up to Asunaprevir with the Potential for Once-Daily Dosing(2016)30 cited
- → Biaryl isoxazolinone antibacterial agents(2005)22 cited
- → Discovery of BMS-986144, a Third-Generation, Pan-Genotype NS3/4A Protease Inhibitor for the Treatment of Hepatitis C Virus Infection(2020)22 cited
- → Discovery of BMS-961955, an allosteric inhibitor of the hepatitis C virus NS5B polymerase(2017)8 cited
- → A Novel Cleavage Protocol For Use With Rf-Encoded Split Pool Synthesis Technology: Product Cleavage and Collection in Standard 96 Well Format(1999)8 cited